Invention Grant
- Patent Title: Selective reduction of proteins
-
Application No.: US15117254Application Date: 2015-02-11
-
Publication No.: US10464997B2Publication Date: 2019-11-05
- Inventor: Damon L. Meyer
- Applicant: SEATTLE GENETICS, INC.
- Applicant Address: US WA Bothell
- Assignee: Seattle Genetics, Inc.
- Current Assignee: Seattle Genetics, Inc.
- Current Assignee Address: US WA Bothell
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo PC
- International Application: PCT/US2015/015369 WO 20150211
- International Announcement: WO2015/123265 WO 20150820
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K47/68 ; C07K1/08 ; C07K1/113 ; C07K1/36

Abstract:
The present invention provides a method for making uncapped cysteine protein preparations, including uncapped engineered cysteine antibody preparations. The methods include, inter alia, contacting a reducing agent with engineered cysteine antibody molecules, each of the antibody molecules having at least one capped engineered cysteine residue and at least one interchain disulfide bond and reacting the reducing agent with the antibody molecules under conditions sufficient to uncap engineered cysteine residues and form cap byproducts. The method also includes removing the cap byproduct during the reduction reaction. Substantially all of the interchain disulfide bonds present in the antibody molecules prior to reduction are retained following reduction. Antibody conjugates and methods for preparing antibody conjugates using uncapped antibody preparations are also described.
Public/Granted literature
- US20160347824A1 SELECTIVE REDUCTION OF PROTEINS Public/Granted day:2016-12-01
Information query